Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: A randomized controlled trial

Diabetes Care

Volumn 40, Issue 7, 2017, Pages 863-871

  Kempf, Kerstin ^a   Altpeter, Bernd ^b   Berger, Janine ^b   Reuß, Oliver ^c   Fuchs, Matthias ^c   Schneider, Michael ^c,d   Gärtner, Babette ^a   Niedermeier, Katja ^a   Martin, Stephan ^a,e  

^a Dusseldorf Catholic Hospital Group   (Germany)

^b German Institute for Telemedicine and Healthpromotion   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GERMANY; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL MENTAL MOTIVATION; METABOLIC REGULATION; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TELEMEDICINE; TREATMENT RESPONSE; AGED; BLOOD; BODY WEIGHT; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIFESTYLE; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; BODY WEIGHT; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; QUALITY OF LIFE; SINGLE-BLIND METHOD; TELEMEDICINE; TREATMENT OUTCOME;

EID: 85021092987     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-0303     Document Type: Conference Paper

References (32)

1. Tuomilehto J, Lindström J, Eriksson JG, et al.; FinnishDiabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
2. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention ormetformin. N Engl J Med 2002;346:393-403
3. Esposito K, Maiorino MI, Ciotola M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009;151:306-314
4. Wing RR; Look AHEAD Research Group. Longterm effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170: 1566-1575
5. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011;54:2506-2514
6. Gregg EW, Chen H, Wagenknecht LE, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489-2496
7. UK ProspectiveDiabetes Study (UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
8. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964-973
9. Kempf K, Schloot NC, Gärtner B, Keil R, Schadewaldt P, Martin S. Meal replacement reduces insulin requirement, HbA1c and weight longterm in type 2 diabetes patientswith.100Uinsulin per day. J HumNutr Diet 2014;27(Suppl. 2):21-27
10. Kempf K, Tankova T, Martin S. ROSSO-inpraxi-international: long-term effects of selfmonitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin. Diabetes Technol Ther 2013;15:89-96
11. Kempf K, DirkM, Kolb H, Hebestreit A, Bittner G,Martin S. The Da VinciMedical-mental motivation program for supporting lifestyle changes in patients with type 2 diabetes. Dtsch Med Wochenschr 2012;137:362-367 [in German]
12. Gandek B,Ware JE, Aaronson NK, et al. Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-1178
13. Hautzinger M, Bailer M. Allgemeine Depressionsskala (ADS). Weinheim, Germany, Beltz, 1993
14. Stunkard AJ,Messick S. The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29:71-83
15. Mayer SB, Jeffreys AS,OlsenMK,McDuffie JR, FeinglosMN, YancyWS Jr. Two dietswith different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. Diabetes Obes Metab 2014;16:90-93
16. D'Agostino RB Sr, Vasan RS, PencinaMJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-753
17. Kempf K, Altpeter B, Berger J, et al. Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in advanced stages of type 2 diabetes-a randomized controlled trial (Abstract). Diabetes 2016;65(Suppl. 1):A183
18. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014 [Internet], 2014. Atlanta, GA, U.S. Department of Health and Human Services. Available from http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 15 November 2015
19. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046
20. Buse JB, Vilsbøll T, Thurman J, et al.; NN9068-3912 (DUAL-II) Trial Investigators. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira). Diabetes Care 2014;37:2926-2933
21. Buse JB, Rosenstock J, Sesti G, et al.; LEAD-6 Study Group. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, openlabel trial (LEAD-6). Lancet 2009;374:39-47
22. Lage MJ, Fabunmi R, Boye KS, Misurski DA. Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy. Adv Ther 2009;26:217-229
23. Buysman EK, Liu F, Hammer M, Langer J. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Adv Ther 2015;32: 341-355
24. Lasa A,Miranda J, BullóM, et al. Comparative effect of twoMediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes. Eur J Clin Nutr 2014;68:767-772
25. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013;347: f5934
26. Welch G, Zagarins SE, Santiago-Kelly P, et al. An internet-based diabetes management platform improves team care and outcomes in an urban Latino population. Diabetes Care 2015;38: 561-567
27. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease selfmanagement program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999;37:5-14
28. O'Connor PJ, Schmittdiel JA, Pathak RD, et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care 2014; 37:3317-3324
29. Lorig K, Ritter PL, Laurent DD, et al. Online diabetes self-management program: a randomized study. Diabetes Care 2010;33:1275-1281
30. Lorig K, Ritter PL, OryMG, Whitelaw N. Effectiveness of a generic chronic disease selfmanagement program for people with type 2 diabetes: a translation study. Diabetes Educ 2013;39:655-663
31. Lorig K, Ritter PL, Villa F, Piette JD. Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials. Diabetes Care 2008;31:408-414
32. Lorig K, Ritter PL, Villa FJ, Armas J. Community-based peer-led diabetes self-management: a randomized trial. Diabetes Educ 2009;35:641-651